IBDEI1OG ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29774,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Disorders,Unspec
 ;;^UTILITY(U,$J,358.3,29774,1,4,0)
 ;;=4^I35.9
 ;;^UTILITY(U,$J,358.3,29774,2)
 ;;=^5007178
 ;;^UTILITY(U,$J,358.3,29775,0)
 ;;=I48.91^^177^1895^3
 ;;^UTILITY(U,$J,358.3,29775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29775,1,3,0)
 ;;=3^Atrial Fibrillation,Unspec
 ;;^UTILITY(U,$J,358.3,29775,1,4,0)
 ;;=4^I48.91
 ;;^UTILITY(U,$J,358.3,29775,2)
 ;;=^5007229
 ;;^UTILITY(U,$J,358.3,29776,0)
 ;;=I49.9^^177^1895^4
 ;;^UTILITY(U,$J,358.3,29776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29776,1,3,0)
 ;;=3^Cardiac Arrhythmia,Unspec
 ;;^UTILITY(U,$J,358.3,29776,1,4,0)
 ;;=4^I49.9
 ;;^UTILITY(U,$J,358.3,29776,2)
 ;;=^5007237
 ;;^UTILITY(U,$J,358.3,29777,0)
 ;;=I50.9^^177^1895^7
 ;;^UTILITY(U,$J,358.3,29777,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29777,1,3,0)
 ;;=3^Heart Failure,Unspec
 ;;^UTILITY(U,$J,358.3,29777,1,4,0)
 ;;=4^I50.9
 ;;^UTILITY(U,$J,358.3,29777,2)
 ;;=^5007251
 ;;^UTILITY(U,$J,358.3,29778,0)
 ;;=I73.9^^177^1895^14
 ;;^UTILITY(U,$J,358.3,29778,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29778,1,3,0)
 ;;=3^PVD,Unspec
 ;;^UTILITY(U,$J,358.3,29778,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,29778,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,29779,0)
 ;;=I87.2^^177^1895^18
 ;;^UTILITY(U,$J,358.3,29779,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29779,1,3,0)
 ;;=3^Venous Insufficiency
 ;;^UTILITY(U,$J,358.3,29779,1,4,0)
 ;;=4^I87.2
 ;;^UTILITY(U,$J,358.3,29779,2)
 ;;=^5008047
 ;;^UTILITY(U,$J,358.3,29780,0)
 ;;=R03.0^^177^1895^6
 ;;^UTILITY(U,$J,358.3,29780,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29780,1,3,0)
 ;;=3^Elevated B/P Reading w/o HTN Dx
 ;;^UTILITY(U,$J,358.3,29780,1,4,0)
 ;;=4^R03.0
 ;;^UTILITY(U,$J,358.3,29780,2)
 ;;=^5019171
 ;;^UTILITY(U,$J,358.3,29781,0)
 ;;=Z71.89^^177^1896^1
 ;;^UTILITY(U,$J,358.3,29781,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29781,1,3,0)
 ;;=3^Counseling,Specified
 ;;^UTILITY(U,$J,358.3,29781,1,4,0)
 ;;=4^Z71.89
 ;;^UTILITY(U,$J,358.3,29781,2)
 ;;=^5063253
 ;;^UTILITY(U,$J,358.3,29782,0)
 ;;=Z71.7^^177^1896^2
 ;;^UTILITY(U,$J,358.3,29782,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29782,1,3,0)
 ;;=3^HIV Counseling
 ;;^UTILITY(U,$J,358.3,29782,1,4,0)
 ;;=4^Z71.7
 ;;^UTILITY(U,$J,358.3,29782,2)
 ;;=^5063251
 ;;^UTILITY(U,$J,358.3,29783,0)
 ;;=Z76.89^^177^1896^3
 ;;^UTILITY(U,$J,358.3,29783,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29783,1,3,0)
 ;;=3^Persons Encountering Health Services for Oth Circumstances
 ;;^UTILITY(U,$J,358.3,29783,1,4,0)
 ;;=4^Z76.89
 ;;^UTILITY(U,$J,358.3,29783,2)
 ;;=^5063304
 ;;^UTILITY(U,$J,358.3,29784,0)
 ;;=E03.9^^177^1897^7
 ;;^UTILITY(U,$J,358.3,29784,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29784,1,3,0)
 ;;=3^Hypothroidism,Unspec
 ;;^UTILITY(U,$J,358.3,29784,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,29784,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,29785,0)
 ;;=E11.9^^177^1897^4
 ;;^UTILITY(U,$J,358.3,29785,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29785,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,29785,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,29785,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,29786,0)
 ;;=E10.9^^177^1897^2
 ;;^UTILITY(U,$J,358.3,29786,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29786,1,3,0)
 ;;=3^DM Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,29786,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,29786,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,29787,0)
 ;;=E11.65^^177^1897^3
 ;;^UTILITY(U,$J,358.3,29787,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29787,1,3,0)
 ;;=3^DM Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,29787,1,4,0)
 ;;=4^E11.65
 ;;
 ;;$END ROU IBDEI1OG
